Classifications

• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K50/00—Feeding-stuffs specially adapted for particular animals
  • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K20/00—Accessory food factors for animal feeding-stuffs
  • A23K20/10—Organic substances
  • A23K20/158—Fatty acids; Fats; Products containing oils or fats
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K20/00—Accessory food factors for animal feeding-stuffs
  • A23K20/10—Organic substances
  • A23K20/189—Enzymes
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K50/00—Feeding-stuffs specially adapted for particular animals
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23K—FODDER
  • A23K50/00—Feeding-stuffs specially adapted for particular animals
  • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
  • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
• • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
  • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
  • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
  • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
  • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
  • Y02A40/81—Aquaculture, e.g. of fish
  • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Definitions

• This invention relates to the use of antimicrobial enzymes, such as oxidases and lysozyme, and a polyunsaturated fatty acid (PUFA), in (monogastric and non-ruminant) animal feed to improve growth and feed conversion ratio of pigs, poultry, fish and veal calves.
• antimicrobial enzymes such as oxidases and lysozyme
• PUFA polyunsaturated fatty acid
• Animals such as pigs, poultry, veal calves and fish are grown intensively for the production of meat, fish and eggs. These animals are fed diets containing a variety of raw materials of animal and/or vegetable origin to supply energy and protein. Most of the feed that is consumed is produced commercially by the compound feed industry but a significant part is produced on the farm and fed directly. The feed is supplemented with vitamins and minerals to meet the requirements of animals for these essential nutrients.
• the feed is also supplemented with coccidiostats to prevent coccidiosis.
• coccidiostats to prevent coccidiosis.
• industrially produced enzymes comprise phytases, alpha-amylases, proteases and various plant cell wall degrading enzymes such as ⁇ -glucanases, endoxylanases and mannanases.
• These enzymes are used to improve growth and feed conversion ratio and to reduce the environmental pollution caused by manure from pigs, poultry and fish.
• antibiotics are used routinely as feed additives.
• the mode of action of these antibiotics on the improvement of growth and feed conversion ratio is still not fully understood.
• the generic term for this class of feed additives is growth promoters.
• growth promoters examples include virginiamycin, tylosin, flavomycin and avoparcin.
• Certain enzymes are known to be active as antimicrobial agents, and these may be used in the preservation of food.
• Glucose oxidase has also been suggested for the preservation of silage fodder and silage grain (WO-A-98/01694, Suomen Sokeri Oy).
• Plant cell wall degrading enzymes such as mannanase and b-glucanases are used as feed additives for diets containing high amounts of b-glucan and mannan to reduce the viscosity in the gastro-intestinal tract of monogastric animals caused by these non-starch polysaccharides. These enzymes also have some antifungal activity but do not exhibit any antibacterial activity.
• the antibacterial enzyme lysozyme has been added as a growth promoter to the feed in monogastric animals (Latvietis, J., etal, In: Nitamine justifystoffe in der
• the present invention provides an animal feed additive composition comprising a mixture of antimicrobial enzymes which can show synergistic effects.
• the effect of the or each enzyme can be enhanced by the presence of one or more PUFAs. This may allow the improvement of growth and feed conversion ratio of animals such as pigs, poultry, veal calves and aquatic or marine animals such as fish, and can allow one to omit an antibiotic as growth promoter.
• a first aspect of the present invention relates to an animal feed additive composition, suitable for a monogastric or non-ruminant animal, the composition comprising at least two antimicrobial enzymes and (as an enzyme enhancer) a polyunsaturated fatty acid (PUFA).
• the enzymes are antibacterial enzymes. These enzymes may be of different types and/or may have different activity.
• One, eg. a first, enzyme may be able to disrupt the cell wall of bacteria.
• the enzyme may be one that can attack or degrade peptidoglycans.
• the enzyme may be able to cleave off peptidoglycans.
• a preferred enzyme for this task is lysozyme.
• This (first) enzyme may be present at a concentration to give from 50,000 to 150,000, such as from 70,000 to
• this first enzyme may be present at an amount to give a concentration in the animal feed of from 1 to 8 grams per kg of feed, preferably from 2 to 7 grams per kg of feed and optimally from 3 to 5 grams per kg of feed.
• the second enzyme may be able to generate a compound that is toxic to the bacteria. This may be the same bacteria, of different, from the bacteria whose cell walls can be disrupted or degraded by the first enzyme.
• the compound is preferably a peroxide, eg. hydrogen peroxide.
• preferred enzyme are oxidases. Particularly preferred is glucose oxidase.
• This second enzyme may be present at a concentration to give from 500 to 1,500, preferably from 700 to 1,300, and optimally from 900 to 1,100 Sarett U per kilogram (or unit) of feed.
• this second enzyme may be present at an amount, by weight, to give a final concentration in the animal feed of from 1 to 8 grams per kg of feed, preferably from 2 to 7 grams per kg of feed, and optimally from 3 to 5 grams per kg of feed.
• Enzymes can function as antimicrobial agents in the following ways: a) disruption of the cell wall; b) generation of a toxic compound; c) removal of an essential nutrient; or d) inactivation of enzymes essential for growth. Each of these will be discussed in turn.
• Microbial cell walls vary in structure for fungi, yeasts, gram negative and gram positive bacteria.
• the fungal and yeast cell wall may be disrupted by mannanases, chitinases and betaglucanases.
• the bacterial cell wall is not sensitive to these enzymes due to a different type of structure.
• Gram positive organisms have a peptidoglycan layer covered by some protein but essentially consists of peptidoglycan only.
• This substrate may be degraded by action of lysozyme (1,4-b-acetylmuramidase) which cleaves peptidoglycans between the Cl of N-acetyl- muramic acid and the C-4 of N-acetylglucosamine.
• lysozyme (1,4-b-acetylmuramidase) which cleaves peptidoglycans between the Cl of N-acetyl- muramic acid and the C-4 of N-acetylglucosamine.
• the peptidoglycan layer is covered by a tight lipopolysaccharide-protein-divalent cation-phospholipid layer in gram negative bacteria. This layer can hinder the efficacy of lysozyme in gram negative bacteria. Agents capable of disrupting this tight lipopolysaccharide layer stimulate the action of lysozyme by giving the enzyme access to the peptidoglycan layer.
• Oxidases are capable of producing hydrogen peroxide which is lethal to most microorganisms.
• Glucose oxidase for example, catalyses the conversion of glucose into gluconic acid and hydrogen peroxide.
• Xanthine oxidase present in milk, is also capable of generating hydrogen peroxide.
• Oxygen may be removed from the media by means of oxidases such as e.g. glucose oxidase. Complete removal of oxygen prevents the growth of aerobic microorganisms.
• Enzymes essential for growth of microorganisms may be inactivated by means of other enzymes.
• Sulfhydryl oxidases for example, are capable of inactivating enzymes which depend on active sulfhydryl groups for their activity.
• the composition can comprise or enzyme enhancer, such as a compound that can significantly improve the activity of the or each antimicrobial (eg. antibacterial) enzyme, preferably in a synergistic manner.
• the enzyme enhancer can comprise one or more polyunsaturated fatty acids, otherwise known as PUFAs.
• the or each PUFA can be of the n-3 or n-6 family. Preferably it is a C18, C20 or C22 PUFA.
• the PUFA can be provided in the form of a free fatty acid, as a fatty acid ester (e.g. methyl or ethyl ester), as a phospholipid and/or in the form of a triglyceride.
• Preferred PUFAs include arachidonic acid (ARA), docosohexaenoic acid (DHA), eicosapentaenoic acid (EPA) and/or ⁇ -linoleic acid (GLA). Of these, ARA is preferred.
• the PUFAs may be from a natural (e.g. vegetable or marine) source or may be derived from a single cell or microbial source. In particular, the PUFA may be produced by a bacteria, fungus or yeast. Fungi are preferred, preferably of the order Mucorales, for example Mortierella, Pythium or Entomophora.
• the preferred source of ARA is from Mortierella alpina or Pythium insidosum.
• the PUFA may be present as an oil. Suitable oils that include ARA are available from DSM N.V, Wateringseweg 1, P.O. Box 1, 2600 MA Delft, The Netherlands, under the trade mark VEVODARTM. Another commercially available oil is ARASCOTM from Martek Corporation, 6480 Dobbin Road, Columbia, MD 21045, United States of America. Other PUFAs are available, for example DHA as a DHA oil (DHASCOTM from Martek Corporation or DHA from Pronova, Norway, under the trade mark EPAXTM).
• the PUFA is preferably at a concentration that it allows it to be added to the animal feed to give a final concentration of from 0J or 1 to 1000, such as from 0.5 to 50 or 1 to 100, and preferably from 1 to 10 grams per kilogram (or unit) of feed.
• All the antimicrobial enzymes can be produced on industrial scale and/or may be recombinant. Lysozyme is commercially available, isolated from egg white, or may be recombinant.
• the or each enzyme may be naturally occurring or may be an (eg. recombinant) variant or mutant thereof.
• the or each antibacterial enzyme is preferably recombinantly produced such as by expression of a heterologous gene or cDNA in a suitable organism, or alternatively by homologous (over)expression of a suitable endogenous gene.
• the glucose oxidase gene for example, has been overexpressed in recombinant systems
• Lysozyme from egg white
• Lysozyme mutants produced by protein engineering
• the antimicrobial enzymes used in the invention will usually be either ones which are not a natural constituent of the animal feed or are present in the feed at a concentration different from its natural concentrations.
• a second aspect of the present invention relates to an animal feed composition comprising at least two antimicrobial enzymes and a PUFA.
• a first enzyme may be able to disrupt the cell wall of bacteria, and a second enzyme may be capable of generating a compound toxic to the bacteria.
• a third aspect of the invention relates to a process for the preparation of an animal feed composition, the process comprising adding to one or more edible feed substance(s) or ingredient(s) two or more antimicrobial enzymes and a PUFA, or an additive of the first aspect.
• the enzymes and/or PUFA can be added to the animal feed composition separately from the feed substance(s) or ingredient (s), individually or in combination with other feed additives.
• the or each enzyme can be an integral part of one of the feed substances. This aspect includes both preparing a feed composition with the two enzymes and PUFA or supplementing an existing feed composition with these compounds.
• a particularly preferred method for the (exogenous) addition of the antimicrobial enzyme to animal feed is to add the or each enzyme as transgenic plant material and/or (e.g. transgenic) seed.
• the enzyme may thus have been synthesized through heterologous gene expression, for example the gene encoding the desired enzyme may be cloned in to a plant expression vector, under control of the appropriate plant expression signals, e.g. a tissue specific promoter, such as a seed specific promoter.
• the expression vector containing the gene encoding the enzyme can be subsequently transformed into plant cells, and transformed cells can be selected for regeneration into whole plants.
• transgenic plants can be grown and harvested, and those parts of the plants containing the heterologous (to the plant) enzyme can be included in one of the compositions, either as such or after further processing.
• Reference here is made to WO-A- 1/14772 which discloses general methods for the (heterologous) expression of enzymes in (transgenic) plants, including methods for seed-specific expression of enzymes.
• the heterologous enzyme may be contained in the seed of the transgenic plants or it may be contained in other plant parts such as roots, stems, leaves, wood, flowers, bark and/or fruit.
• transgenic plant material e.g. transgenic seed containing the antimicrobial enzymes
• the addition of the enzyme in the form of transgenic plant material may require the processing of the plant material so as to make the enzyme available, or at least improve its availability.
• Such processing techniques may include various mechanical (eg. milling and/or grinding) techniques or thermomechanical treatments such as extrusion or expansion.
• the antibacterial enzymes may be added to the feed composition at a concentration which varies as a function of diet composition, type of enzyme and target animal species.
• compositions of the invention do not contain any antibiotics.
• the composition ⁇ ) of the invention may also be free of a mineral component (such as zinc and/or iodine) and/or an immunomodulating agent (such as ascorbic acid).
• a mineral component such as zinc and/or iodine
• an immunomodulating agent such as ascorbic acid.
• each of the two antimicrobial enzymes and the PUFA can all be produced by a micro- organism, it is preferred that the composition is free of microorganisms that produced any of these compounds (or microorganisms from Streptomyces).
• the composition may be devoid of microorganisms that produce lactic acid inside the animal (eg. those of the genus Lactobacillus or Enterococcus).
• a fourth aspect of the present invention relates to a process for promoting growth and/or feed conversion in a monogastric or non-ruminant animal, the process comprising feeding the animal at least two antimicrobial enzymes and a PUFA or a feed composition of the first or second aspect or preparable by the third aspect.
• Suitable animals include farm, monogastric and/or non-ruminant animals such as pigs (or piglets), poultry (such as chickens, turkeys), calves or veal or aquatic (e.g. marine) animals (for example fish).
• farm, monogastric and/or non-ruminant animals such as pigs (or piglets), poultry (such as chickens, turkeys), calves or veal or aquatic (e.g. marine) animals (for example fish).
• a fifth aspect relates to the use of a composition of the first aspect as an additive for a monogastric or non-ruminant animal feed composition.
• Preferred features and characteristics of one aspect of the present invention are applicable to another aspect mutatis mutandis.
• Glucose oxidase (EC 1.1.3.4), an oxidase capable of generating hydrogen peroxide, was obtained as a commercial product under the trade mark FERMIZYME GOTM from DSM/Royal Gist-brocades, Bakery Ingredients Division, PO Box 1, 2600 MA DELFT, The Netherlands.
• This enzyme preparation exhibits an activity of 500 Sarett Units per gram.
• One Sarett unit is the amount of enzyme that will cause an uptake of 10mm 3 of oxygen per minute in a Warburg manometer at 30° C in the presence of excess oxygen and 3.3% glucose monohydrate in a phosphate buffer pH 5.9.
• the enzyme was produced by the fungus Aspergillus niger.
• Lysozyme obtained from chicken egg-white was obtained as a commercial product under the trade mark DELVOZYMETM from DSM/Royal Gist-brocades, Dairy Ingredients Group, PO Box 1, 2600 MA DELFT, The Netherlands.
• the product contains 5.1 x 10 6 Shugar units/ml product.
• One Shugar unit is defined as the amount of enzyme which causes a decrease of absorbance of 0.001 per minute at 450 nm and pH 6J at 25°C in a suspension of Micrococcus lysodeikticus (0.25 mg/ml) obtainable from Sigma Chemicals.
• Arachidonic acid was also obtained from DSM/Royal Gist-brocades under the trade mark VEVODARTM. This is in the form of a microbial oil (ARA content at least 35%) obtained by culturing the fungus Mortierella alpina.
• the temperature was gradually reduced from 28°C during the first week to 23 °C during the last week of the experiment.
• Humidity in the broiler unit was approximately 60% during the experimental period.
• the animals had been vaccinated against New Castle disease (using the spray method) at an age of one and fourteen days.
• the experiment lasted 33 days, comprising a pre-test period of 5 days and a test period of 28 days.
• the experimental diets were offered ad lib. to the animals. Water was freely available. The feed was cold pelleted (temperatures were kept below 65 °C) at a diameter of 3 millimeter.
• the experiment comprised the following treatments:
• Soya bean meal (45.4% crude protein) 22
• the enzymes and arachidonic acid were added to this basal diet by mixing it first with a carrier.
• Body weight and pen feed consumption were measured weekly.
• the basal diet was a typical American diet, of the composition:
• the experiment comprised the following treatments (Examples 6 to 10): a) basal diet (negative control); b) basal diet + glucose oxidase (1000 Sarett U/kg feed); c) basal diet + lysozyme (100,000 Shugar units/kg of feed); d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed); e) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
• the experiment comprised the following treatments (Examples 11 to 15): a) basal diet (negative control); b) basal diet + glucose oxidase (1000 Sarett U/kg feed); c) basal diet + lysozyme (100,000 Shugar units/kg of feed); d) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed); and e) basal diet + glucose oxidase (1000 Sarett U/kg of feed) + lysozyme (100,000 Shugar units/kg of feed) + arachidonic acid to a final concentration of 1 g/kg of feed.
• the results obtained, in terms of growth and feed conversion, are shown below in

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Polymers & Plastics (AREA)
• Engineering & Computer Science (AREA)
• Zoology (AREA)
• Animal Husbandry (AREA)
• Food Science & Technology (AREA)
• Birds (AREA)
• Insects & Arthropods (AREA)
• Marine Sciences & Fisheries (AREA)
• Fodder In General (AREA)
• Feed For Specific Animals (AREA)
• Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Priority Applications (14)

Applications Claiming Priority (2)

Publications (1)

Family

ID=8235112

Family Applications (1)

Country Status (21)

Cited By (34)

Families Citing this family (6)

Citations (5)

• 1999
  • 1999-10-15 AU AU64730/99A patent/AU753232B2/en not_active Ceased
  • 1999-10-15 CN CN99812124A patent/CN1323166A/zh active Pending
  • 1999-10-15 CZ CZ20011328A patent/CZ20011328A3/cs unknown
  • 1999-10-15 BR BR9914555-3A patent/BR9914555A/pt not_active Application Discontinuation
  • 1999-10-15 EP EP99952589A patent/EP1121021A1/en not_active Withdrawn
  • 1999-10-15 PL PL99347250A patent/PL347250A1/xx not_active Application Discontinuation
  • 1999-10-15 TR TR2001/01074T patent/TR200101074T2/xx unknown
  • 1999-10-15 JP JP2000575375A patent/JP2002527046A/ja active Pending
  • 1999-10-15 NZ NZ510932A patent/NZ510932A/xx unknown
  • 1999-10-15 KR KR1020017004695A patent/KR20010089301A/ko not_active Application Discontinuation
  • 1999-10-15 SK SK502-2001A patent/SK5022001A3/sk unknown
  • 1999-10-15 IL IL14238499A patent/IL142384A0/xx unknown
  • 1999-10-15 ID IDW20010826A patent/ID28812A/id unknown
  • 1999-10-15 CA CA002346075A patent/CA2346075A1/en not_active Abandoned
  • 1999-10-15 GB GB0014421A patent/GB2349794B/en not_active Expired - Fee Related
  • 1999-10-15 HU HU0104001A patent/HUP0104001A2/hu unknown
  • 1999-10-15 WO PCT/EP1999/007835 patent/WO2000021381A1/en not_active Application Discontinuation
  • 1999-10-15 NL NL1013308A patent/NL1013308C2/nl not_active IP Right Cessation
• 2001
  • 2001-03-03 HK HK01101563A patent/HK1030855A1/xx not_active IP Right Cessation
  • 2001-04-05 ZA ZA200102825A patent/ZA200102825B/en unknown
  • 2001-04-10 NO NO20011833A patent/NO20011833L/no not_active Application Discontinuation

Patent Citations (5)

Also Published As

Similar Documents

Legal Events